Related references
Note: Only part of the references are listed.The Soluble CTLA-4 Splice Variant Protects From Type 1 Diabetes and Potentiates Regulatory T-Cell Function
Kay D. Gerold et al.
DIABETES (2011)
CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population
Rabbani Syed et al.
INDIAN JOURNAL OF DERMATOLOGY (2010)
CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data
Stanca A. Birlea et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not
Greggory S. LaBerge et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
CT60 genotype does not affect CTLA-4 isoform expression despite association to TID and AITD in northern Sweden
Sofia Mayans et al.
BMC MEDICAL GENETICS (2007)
Association of CTLA4 polymorphism with regulatory T cell frequency
SF Atabani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus:: a re-evaluation of the 3′+6230G> polymorphism
SM Anjos et al.
GENES AND IMMUNITY (2005)
CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases
A Blomhoff et al.
PIGMENT CELL RESEARCH (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
H Ueda et al.
NATURE (2003)
Share Paper
